Pharmaceutical News and Articles

FDA Approves Merilog (insulin-aspart-szjj), a Biosimilar to NovoLog

Lundbeck’s Potential Treatment Amlenetug for Multiple System Atrophy Receives Fast Track Designation From the FDA

The FDA has granted Fast Track Designation to Lundbeck s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MS

FDA Grants Fast Track Designation to PleoPharma, Inc's Investigational New Drug, PP-01, for the Mitigation of Cannabis Withdrawal Symptoms in Patients With Cannabis Use Disorder

PleoPharma, Inc., a privately held company focused on finding treatments for cannabis related health issues, announced today that the U.S. Food and Drug Adminis

Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome

Innate Pharma SA (Euronext Paris IPH Nasdaq IPHA) ( Innate or the Company ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakth

FDA Approves Xbryk (denosumab-dssb), a Biosimilar to Xgeva

Can't Find a Gastroenterologist? You're Not Alone

Nearly 50 million Americans live in counties with no local gastroenterologist. from gallstones and gastric reflux to colon cancer. A team led by Dr. Xiaohan Yin

FDA Approves Ospomyv (denosumab-dssb), a Biosimilar to Prolia

FDA Approves Romvimza (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor

FDA Approves Vimkunya (chikungunya vaccine, recombinant) for Prevention of Disease Caused by Chikungunya Virus

FDA Approves Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) for Prevention of Invasive Meningococcal Disease Caused by Serogroups A, B, C, W, and Y